3 phases of management:
- (1) radiographic and other imaging staging studies
- (2) diagnosis
- (3) treatment
- Consideration of:
- Histogenic type of tumor
- Local extent
- Possibility of distant disease
- Clinical factors:
- Age, size, occupation, life-style, expectations
- Consideration of:
Incidence of musculoskeletal tumors (USA):
|
Primary osseous malignancies |
~2,500/yr |
|
Primary osseous benign tumors |
200,000-300,000/yr |
|
Osseous metastases |
250,000-300,000/yr |
|
Soft-tissue sarcomas |
~8,000/yr |
|
Soft-tissue benign |
400,000-500,000/yr |
- DEFINITIONS
- STAGING TECHNIQUES
- INTERPRETATION OF THE BIOPSY
- SURGICAL STAGING SYSTEMS
- PROGNOSTIC FACTORS FOR BONE AND SOFT-TISSUE SARCOMAS
- METASTATIC DISEASE
- SURVEILLANCE AFTER SARCOMA RESECTION
- References for Staging, Biopsy, Terminology, and Surveillance of Musculoskeletal Tumors
- THE SARCOMA REGISTRY